Patents Assigned to Merci & Co., Inc.
  • Cholesterol lowering compounds
    Patent number: 5260332
    Abstract: New Zaragozic acids have been isolated from a culture of MF5465. These compounds and their derivatives are active as squalene synthetase inhibitors and are useful in the treatment of hypercholesterolemia.
    Type: Grant
    Filed: February 7, 1992
    Date of Patent: November 9, 1993
    Assignee: Merci & Co., Inc.
    Inventor: Claude Dufresne